Wiley Matthew T. - Chief Commercial Officer at Definium Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
DFTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Wiley Matthew T. since 12 Mar 2025

Holdings reported by Wiley Matthew T. for Definium Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 115,000 $1,539,873 $13.39 03 Feb 2026 Direct
Stock Option (Right to Buy) 350,000 17 Mar 2025 Direct Common Shares

Transactions reported by Wiley Matthew T. for Definium Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.